These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7942381)

  • 1. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs.
    Bording A; Nymark K; Smidt E
    Acta Vet Scand; 1994; 35(2):155-63. PubMed ID: 7942381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
    Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
    Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on the incidence of atrophic rhinitis of vaccination of sows with a vaccine containing Pasteurella multocida toxin.
    Pedersen KB; Barfod K
    Nord Vet Med; 1982; 34(7-9):293-302. PubMed ID: 7177813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
    To H; Someno S; Nagai S
    Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.
    Petersen SK; Foged NT; Bording A; Nielsen JP; Riemann HK; Frandsen PL
    Infect Immun; 1991 Apr; 59(4):1387-93. PubMed ID: 1706320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
    Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
    Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs.
    Foged NT
    APMIS Suppl; 1992; 25():1-56. PubMed ID: 1576005
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
    Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
    Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
    Rajeev S; Nair RV; Kania SA; Bemis DA
    Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine efficacy for reducing turbinate atrophy and improving growth rate in piggeries with endemic atrophic rhinitis.
    Kabay MJ; Mercy AR; Lloyd JM; Robertson GM
    Aust Vet J; 1992 May; 69(5):101-3. PubMed ID: 1627085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies.
    Foged NT; Nielsen JP; Jorsal SE
    Vet Rec; 1989 Jul; 125(1):7-11. PubMed ID: 2528856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
    van Diemen PM; de Vries Reilingh G; Parmentier HK
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of neutralizing antibodies against Pasteurella multocida toxin in swine with atrophic rhinitis].
    Bechmann G; Schöss P
    Dtsch Tierarztl Wochenschr; 1991 Aug; 98(8):310-2. PubMed ID: 1935682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an atrophic rhinitis vaccine under controlled conditions.
    Voets MT; Klaassen CH; Charlier P; Wiseman A; Descamps J
    Vet Rec; 1992 Jun; 130(25):549-53. PubMed ID: 1496755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of a Bordetella live vaccine on the occurrence and manifestation of atrophic rhinitis suum and the aerogenous infection burden in field strains of the agent].
    Ehser U; Mehlhorn G; Mietke H
    Dtsch Tierarztl Wochenschr; 1993 Sep; 100(9):355-9. PubMed ID: 8223236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A field evaluation of Nobi-Vac atrophic rhinitis vaccine.
    de Jong MF; Bouwkamp FT; Oosterwoud RA
    Vet Q; 1987 Jan; 9(1):49-59. PubMed ID: 3564317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
    Seo J; Pyo H; Lee S; Lee J; Kim T
    Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica.
    Riising HJ; van Empel P; Witvliet M
    Vet Rec; 2002 May; 150(18):569-71. PubMed ID: 12019649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
    Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
    Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.